MF
ICPT

Magnetar Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Magnetar Financial’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,407,209
Closed -$44.6M – 603
2023
Q3 		$44.6M Buy
+2,407,209
New +$27.2M 1.14% 26

Magnetar Financial's ICPT Position: Q4 2023 in Review

Magnetar Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 2,407,209 shares — an estimated $44.6M sold.

Magnetar Financial first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $44.6M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Magnetar Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Magnetar Financial sold 2,407,209 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $44.6M.
  • Magnetar Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Magnetar Financial's Intercept Pharmaceuticals, Inc. position peaked at $44.6M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Magnetar Financial's 13F filing for Q4 2023, filed 13 Feb 2024.